Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Feb 25 | ADMA ADMA Biologics | Common Stock | Grant | Acquire A | No | No | 0 | 10,889 | 0.00 | 87,330 |
19 Feb 25 | ADMA ADMA Biologics | Stock Option Common Stock | Grant | Acquire A | No | No | 16.07 | 16,279 | 261.60 k | 16,279 |
12 Feb 25 | MRKR Marker Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.59 | 30,000 | 47.70 k | 30,000 |
23 Dec 24 | MRKR Marker Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 3.2 | 11,085 | 35.47 k | 325,370 |
27 Nov 24 | ADMA ADMA Biologics | Common Stock | Option exercise | Acquire M | Yes | No | 10.8 | 9,000 | 97.20 k | 2,124,671 |
27 Nov 24 | ADMA ADMA Biologics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 10.8 | 9,000 | 97.20 k | 0 |
13 Jun 24 | ELEV Elevation Oncology | Stock Option Common Stock | Grant | Acquire A | Yes | No | 3.35 | 35,000 | 117.25 k | 35,000 |